H2020-JTI-IMI2-2020-20-two-stage
H2020-JTI-IMI2-2020-20-two-stage
- Programme
- H2020
- Funded projects (dataset)
- 6
- EU contribution (sum)
- €133,008,956
- Portal deadline
- —
Leading topic in historical projects: IMI2-2020-20-01
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- AU1 coordinated
- EUROPEAN VACCINE INITIATIVE1 coordinated
- RISE1 coordinated
- STICHTING ONCODE INSTITUTE1 coordinated
- RADBOUDUMC1 coordinated
- NUID UCD1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- UOXF3 topic projects
- UNIVERSITY COLLEGE LONDON2 topic projects
- 2-CONTROL APS1 topic projects
- ABBVIE INC1 topic projects
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 topic projects
- Leiden University Medical Center1 topic projects
- IABS-EU1 topic projects
- Atturos1 topic projects
- BMS1 topic projects
- PEI1 topic projects
- CRITICAL PATH INSTITUTE, LIMITED1 topic projects
- CUREVAC AG1 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 2 shared
- ABBVIE INC · IDIBAPS-CERCA2 shared
US ↔ ES
- PFIZER · IDIBAPS-CERCA2 shared
UK ↔ ES
- 2 shared
- 2 shared
- ABBVIE INC · PFIZER2 shared
US ↔ UK
- ABBVIE INC · HOSPITAL CLINIC DE BARCELONA2 shared
US ↔ ES
- PFIZER · HOSPITAL CLINIC DE BARCELONA2 shared
UK ↔ ES
- UNIVERSITY COLLEGE LONDON · UOXF2 shared
UK ↔ UK
- 2 shared
- STICHTING ONCODE INSTITUTE · TRANSGENE SA1 shared
NL ↔ FR
- STICHTING ONCODE INSTITUTE · KNAW1 shared
NL ↔ NL
- STICHTING ONCODE INSTITUTE · ASTRAZENECA AB1 shared
NL ↔ SE
- STICHTING ONCODE INSTITUTE · XENOPAT SL1 shared
NL ↔ ES
- STICHTING ONCODE INSTITUTE · NKI AVL1 shared
NL ↔ NL
- 1 shared
- 1 shared
- STICHTING ONCODE INSTITUTE · GRL1 shared
NL ↔ UK
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 27.83
- Median orgs / project
- 28
- Min / max orgs
- 17 – 41
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- United Kingdom30
- Germany30
- Netherlands23
- Italy16
- Sweden12
- Belgium11
- Switzerland9
- Spain8
- France7
- Denmark6
- United States5
- Portugal3
- Ireland3
- Norway2
- South Africa1
- Israel1
Organization types
- university43 orgs · 51 rows
- research_institute43 orgs · 45 rows
- company26 orgs · 30 rows
- sme19 orgs · 19 rows
- other12 orgs · 13 rows
- public_body9 orgs · 9 rows
Topics in funded projects
- IMI2-2020-20-01IMI2-2020-20-01· 1 projects
- IMI2-2020-20-02IMI2-2020-20-02· 1 projects
- IMI2-2020-20-03IMI2-2020-20-03· 1 projects
- IMI2-2020-20-04IMI2-2020-20-04· 1 projects
- IMI2-2020-20-05IMI2-2020-20-05· 1 projects
- IMI2-2020-20-06IMI2-2020-20-06· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| UNITE4TB ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS | H2020 | €92,500,000 |
| Inno4Vac Innovations to accelerate vaccine development and manufacture | H2020 | €18,600,000 |
| HIPPOCRATES Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States | H2020 | €10,210,993 |
| PERSIST-SEQ Building a reproducible single-cell experimental workflow to capture tumour cell persistence | H2020 | €7,057,980 |
| RealHOPE Real World Handling of Protein Drugs - Exploration, Evaluation and Education | H2020 | €3,139,984 |
| PROTECT-trial Proton versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy | H2020 | €1,500,000 |